Literature DB >> 3025766

Specific binding of a phenyl-pyridazinium derivative endowed with GABAA receptor antagonist activity to rat brain.

M Heaulme, J P Chambon, R Leyris, C G Wermuth, K Biziere.   

Abstract

SR 95531 has been shown to be a potent, selective, reversible and competitive GABAA antagonist. In the present study we report that (3H)SR 95531 binds with high affinity and in a specific and saturable manner to rat brain membranes. Scatchard analysis revealed two binding sites (KD: 6 nM; Bmax: 0.24 pmol/mg protein and KD: 38 nM; Bmax: 0.66 pmol/mg protein). Only GABA ligands were effective displacers of (3H)SR 95531. The respective IC50 values obtained with these compounds suggests that (3H)SR 95531 labels the GABA receptor in its antagonist conformation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025766     DOI: 10.1016/0028-3908(86)90148-6

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  2 in total

1.  Effects of GABA antagonists, SR 95531 and bicuculline, on GABAA receptor-regulated chloride flux in rat cortical synaptoneurosomes.

Authors:  S Yu; I K Ho
Journal:  Neurochem Res       Date:  1990-09       Impact factor: 3.996

2.  Effects of bicuculline on [3H]SR 95531 binding in discrete regions of rat brains.

Authors:  Y Ito; D K Lim; Y Hayase; Y Murakoshi; I K Ho
Journal:  Neurochem Res       Date:  1992-04       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.